Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis
- PMID: 20554018
- PMCID: PMC2910817
- DOI: 10.1016/j.freeradbiomed.2010.05.034
Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis
Abstract
Omeprazole is a mainstay of therapy for gastroesophageal reflux disease (GERD) and gastritis, and is increasingly used as an over-the-counter remedy for dyspepsia. Omeprazole acts by selectively oxidizing thiol targets in the gastric proton pump, but it also appears to be toxic to the gastric mucosa. We hypothesized that omeprazole toxicity is due to non-specific oxidation of cell structures other than the proton pump, and tested the efficacy of antioxidants to prevent omeprazole-induced toxicity in isolated rabbit gastric glands. Toxicity was measured by uptake and converstion of calcein-AM, following three hours of exposure to omeprazole and a non-selective thiol-oxidant, monochloramine. Intracellular concentration of Zn(2+) and the capacity to maintain luminal acidity were monitored using the fluorescent reporters fluozin-3 and Lysosensor DND-160, respectively. Both omeprazole and monochloramine caused marked reduction in cell viability. The toxicity of omeprazole was independent of monochloramine toxicity. The thiol reducing agent dithiothreitol protected gastric glands from injury. The oxidant scavenger Vitamin C also protected, and did not impair the anti-secretory effects of omeprazole. Thus, omeprazole toxicity appears to be oxidative and preventable with antioxidant therapy, including Vitamin C. Vitamin C may be a safe and efficacious addition to treatments requiring the use of PPIs.
Copyright 2010 Elsevier Inc. All rights reserved.
Figures







Similar articles
-
Monochloramine-induced toxicity and dysregulation of intracellular Zn2+ in parietal cells of rabbit gastric glands.Am J Physiol Gastrointest Liver Physiol. 2010 Jul;299(1):G170-8. doi: 10.1152/ajpgi.00355.2009. Epub 2010 Apr 29. Am J Physiol Gastrointest Liver Physiol. 2010. PMID: 20430873 Free PMC article.
-
Thiol-oxidant monochloramine mobilizes intracellular Ca2+ in parietal cells of rabbit gastric glands.Am J Physiol Cell Physiol. 2007 Nov;293(5):C1687-97. doi: 10.1152/ajpcell.00189.2006. Epub 2007 Feb 7. Am J Physiol Cell Physiol. 2007. PMID: 17287368
-
Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats.Dig Dis Sci. 2007 May;52(5):1219-24. doi: 10.1007/s10620-006-9253-7. Epub 2007 Mar 15. Dig Dis Sci. 2007. PMID: 17357842
-
[New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].Presse Med. 2004 Jun 19;33(11):746-54. doi: 10.1016/s0755-4982(04)98731-3. Presse Med. 2004. PMID: 15257232 Review. French.
-
Omeprazole: a comprehensive review.Pharmacotherapy. 1993 Jan-Feb;13(1):46-59. Pharmacotherapy. 1993. PMID: 8437967 Review.
Cited by
-
Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer.Oxid Med Cell Longev. 2020 Mar 28;2020:3457890. doi: 10.1155/2020/3457890. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32308801 Free PMC article. Review.
-
Evaluation of mutagenesis, necrosis and apoptosis induced by omeprazole in stomach cells of patients with gastritis.Cancer Cell Int. 2022 Apr 18;22(1):154. doi: 10.1186/s12935-022-02563-5. Cancer Cell Int. 2022. PMID: 35436881 Free PMC article.
-
A Novel Method for Pain Relief in Chronic Pancreatitis: an Old Drug in a New Pack: a Controlled Study.Indian J Surg. 2017 Dec;79(6):549-554. doi: 10.1007/s12262-016-1526-6. Epub 2016 Jul 16. Indian J Surg. 2017. PMID: 29217908 Free PMC article.
-
Antioxidative defense against omeprazole-induced toxicogenetical effects in Swiss mice.Pharmacol Rep. 2021 Apr;73(2):551-562. doi: 10.1007/s43440-021-00219-1. Epub 2021 Jan 21. Pharmacol Rep. 2021. PMID: 33476036
-
Inhibitors of gastric acid secretion increase oxidative stress and matrix metalloproteinase-2 activity leading to vascular remodeling.Mol Cell Biochem. 2024 Nov;479(11):3141-3152. doi: 10.1007/s11010-023-04921-x. Epub 2024 Feb 1. Mol Cell Biochem. 2024. PMID: 38302836
References
-
- Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989;321:1562–1566. - PubMed
-
- Karam SM, Forte JG. Inhibiting gastric H(+)-K(+)-ATPase activity by omeprazole promotes degeneration and production of parietal cells. Am J Physiol. 1994;266:G745–G758. - PubMed
-
- Alvarez A, Ibiza MS, Andrade MM, Blas-Garcia A, Calatayud S. Gastric antisecretory drugs induce leukocyte-endothelial cell interactions through gastrin release and activation of CCK-2 receptors. J Pharmacol Exp Ther. 2007;323:406–413. - PubMed
-
- Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, Lamers CB, Jansen JB, Dalenback J, Snel P, Nelis GF, Meuwissen SG. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996;334:1018–1022. - PubMed
-
- Kuipers EJ, Uyterlinde AM, Pena AS, Hazenberg HJ, Bloemena E, Lindeman J, Klinkenberg-Knol EC, Meuwissen SG. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995;90:1401–1406. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical